HOME >> BIOLOGY >> NEWS
Hutchinson Center researchers first to induce state of suspended animation in model vertebrate organism

Last February, a toddler in Alberta, Canada, made headlines worldwide after she wandered outside and nearly froze to death. Although her heart stopped beating for two hours and her body temperature was 61 degrees when she was found lying face down in the snow, 14-month-old Erika Nordby made a complete, stunning recovery.

While such recovery from biological limbo seemingly defies scientific or medical explanation, researchers at Seattle's Fred Hutchinson Cancer Research Center have developed a method to induce a similar state of so-called suspended animation in the zebrafish, a relatively new model of vertebrate developmental biology.

Their work, the first demonstration of this phenomenon in a vertebrate model organism highly suitable to laboratory analysis, will be described tomorrow in the June 12 issue of the Proceedings of the National Academy of Sciences (Early Edition No. 24).

This discovery, by Mark Roth, Ph.D., a member of the Hutchinson Center's Basic Sciences Division, promises to open new paths of research into understanding the phenomenon of suspended animation. The achievement ultimately could lead to new ways to treat cancer and prevent ischemic injury from insufficient blood supply to organs and tissues.

Roth, in collaboration with postdoctoral research fellow Pam Padilla, Ph.D., discovered that after 24 hours of oxygen deprivation - resulting in cessation of all observable metabolic activity, including heartbeat - zebrafish embryos can resume a normal course of development with no harmful effects on their health or growth.

Roth's studies on biological limbo may shed light on two problems that perplex cancer biologists: the control of stem-cell division and how oxygen deprivation affects tumor growth.

"We typically think of cancer cells as growing out of control," said Roth, also an affiliate associate professor of biochemistry at the University of Washington School of Medicine. "But actually, within a tumor there are many type
'"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
10-Jun-2001


Page: 1 2 3

Related biology news :

1. Intel and Fred Hutchinson to explore the use of nanotechnology tools for early disease detection
2. American Association for Cancer Research honors Fred Hutchinson Cancer Research Center investigator
3. Fred Hutchinson Cancer Research Center, University of Washington join in national effort to study health impact of toxic substances
4. Digging for genetic fossils: Hutchinson Center researchers solve structure of ancient biological molecule
5. Fred Hutchinson Cancer Research Center to lead international team to accelerate investigation of immune-related genes
6. Hutchinson Center researcher awarded Block lectureship
7. White House honors Hutchinson Center Scientist with Presidential Early Career Award
8. Hutchinson Center to lead $11.5 million ovarian-cancer research consortium
9. Fred Hutchinson Cancer Research Center researcher one of five awarded $1 million distinguished young scholars grant
10. Fred Hutchinson Cancer Research Center And Targeted Genetics Announces Issuance Of Braod Patent Covering Antigen-Specific T Cell Expansion
11. Hutchinson Center Director Wins Americas Nobel

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2019)... ... June 13, 2019 , ... KICVentures announced today its plans ... Orthopedic and Pain Management-Driven ASC Conference in Chicago on Thursday, June 13th at 6:30 ... Dr. Chicago, IL in the 3rd floor Ticino Hospitality room in space #74T. , ...
(Date:6/11/2019)... ... 10, 2019 , ... Improved Pharma LLC announces the publication of “Predictive and ... The article was published online on April 29th, 2019. The authors are Stephen ... Chen of Purdue University. , The article is the most recent addition to a ...
(Date:6/6/2019)... ... June 05, 2019 , ... Ziegler, a ... advisor to Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by PathGroup. ... that provides services to more than one dozen hospitals and surgery centers in ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... ... June 17, 2019 , ... ... entered into an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) ... rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 ...
(Date:6/11/2019)... CITY, Calif. (PRWEB) , ... June 10, 2019 ... ... (IOPP) today announced IOPP will add 80 of its scientific journals to DeepDyve’s ... of physics-related content to DeepDyve’s continually expanding library of more than 20 million ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms ... cancer demand breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric ... with engineered T cell receptors known as “CARs”. The CAR enables the final product ...
(Date:5/22/2019)... ... 22, 2019 , ... Artemis (formerly Agrilyst), the leading enterprise Cultivation ... round co-led by Astanor Ventures and Talis Capital with participation ... iSelect Fund . The company has raised $11.75m to date and will use the ...
Breaking Biology Technology:
Cached News: